Regulation of the human papillomavirus type 16 late promoter by E7 and the cell cycle

Virology

Volumn 443, Issue 1, 2013, Pages 11-19

  Bodily, Jason M ^a   Hennigan, Christine ^a,b   Wrobel, Gary A ^a   Rodriguez, Cynthia M ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

CDK; Differentiation; E2; E2F; E7; Late promoter; Papillomavirus

Indexed keywords

CYCLIN DEPENDENT KINASE; GLYCOPROTEIN E2; PROTEIN E7; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE ACTIVATION; GENE ACTIVITY; GENE CONTROL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

CELL CYCLE; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PROMOTER REGIONS, GENETIC; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 84879785793     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.04.033     Document Type: Article

References (57)

1. Avvakumov N., Torchia J., Mymryk J.S. Interaction of the HPV E7 proteins with the pCAF acetyltransferase. Oncogene 2003, 22:3833-3841.
2. Bedell M.A., Hudson J.B., Golub T.R., Turyk M.E., Hosken M., Wilbanks G.D., Laimins L.A. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 1991, 65:2254-2260.
3. Berk A.J. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 2005, 24:7673-7685.
4. Bodily J., Laimins L.A. Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol. 2011, 19:33-39.
5. Bodily J.M., Alam S., Meyers C. Regulation of human papillomavirus type 31 late promoter activation and genome amplification by protein kinase C. Virology 2006, 348:328-340.
6. Bodily J.M., Mehta K.P., Cruz L., Meyers C., Laimins L.A. The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle. J. Virol. 2011, 85:8852-8862.
7. Bodily J.M., Mehta K.P., Laimins L.A. Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res. 2011, 71:1187-1195.
8. Bodily J.M., Meyers C. Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter. J. Virol. 2005, 79:3309-3321.
9. Brehm A., Nielsen S.J., Miska E.A., McCance D.J., Reid J.L., Bannister A.J., Kouzarides T. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J. 1999, 18:2449-2458.
10. Davy C.E., Jackson D.J., Raj K., Peh W.L., Southern S.A., Das P., Sorathia R., Laskey P., Middleton K., Nakahara T., Wang Q., Masterson P.J., Lambert P.F., Cuthill S., Millar J.B., Doorbar J. Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes. J. Virol. 2005, 79:3998-4011.
11. Fehrmann F., Klumpp D.J., Laimins L.A. Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J. Virol. 2003, 77:2819-2831.
12. Frazer I.H. Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology 2009, 384:410-414.
13. Freije A., Ceballos L., Coisy M., Barnes L., Rosa M., De Diego E., Blanchard J.M., Gandarillas A. Cyclin E drives human keratinocyte growth into differentiation. Oncogene 2012, 10.1038/onc.2012.22.
14. Frolov M.V., Dyson N.J. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 2004, 117:2173-2181.
15. Gammoh N., Grm H.S., Massimi P., Banks L. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator. J. Virol. 2006, 80:1787-1797.
16. Gammoh N., Isaacson E., Tomaic V., Jackson D.J., Doorbar J., Banks L. Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2. Oncogene 2009, 28:2299-2304.
17. Gandarillas A., Davies D., Blanchard J.M. Normal and c-Myc-promoted human keratinocyte differentiation both occur via a novel cell cycle involving cellular growth and endoreplication. Oncogene 2000, 19:3278-3289.
18. Grassmann K., Rapp B., Maschek H., Petry K.U., Iftner T. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 1996, 70:2339-2349.
19. Gunasekharan V., Hache G., Laimins L. Differentiation-dependent changes in levels of C/EBPbeta repressors and activators regulate HPV-31 late gene expression. J. Virol 2012.
20. Helt A.M., Funk J.O., Galloway D.A. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells. J. Virol. 2002, 76:10559-10568.
21. Helt A.M., Galloway D.A. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J. Virol. 2001, 75:6737-6747.
22. Hummel M., Hudson J.B., Laimins L.A. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 1992, 66:6070-6080.
23. Isaacson Wechsler E., Wang Q., Roberts I., Pagliarulo E., Jackson D., Untersperger C., Coleman N., Griffin H., Doorbar J. Reconstruction of human papillomavirus type 16-mediated early-stage neoplasia implicates E6/E7 deregulation and the loss of contact inhibition in neoplastic progression. J. Virol. 2012, 86:6358-6364.
24. Klingelhutz A.J., Roman A. Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology 2012, 424:77-98.
25. Kukimoto I., Kanda T. Displacement of YY1 by differentiation-specific transcription factor hSkn-1a activates the P(670) promoter of human papillomavirus type 16. J. Virol. 2001, 75:9302-9311.
26. Kukimoto I., Takeuchi T., Kanda T. CCAAT/enhancer binding protein beta binds to and activates the P670 promoter of human papillomavirus type 16. Virology 2006, 346:98-107.
27. Longworth M.S., Wilson R., Laimins L.A. HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. EMBO J. 2005, 24:1821-1830.
28. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep. 2007, 56:1-24.
29. McCance D.J., Kopan R., Fuchs E., Laimins L.A. Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc. Nat. Acad. Sci. U.S.A 1988, 85:7169-7173.
30. McLaughlin-Drubin M.E., Huh K.W., Munger K. Human papillomavirus type 16 E7 oncoprotein associates with E2F6. J. Virol. 2008, 82:8695-8705.
31. Middleton K., Peh W., Southern S., Griffin H., Sotlar K., Nakahara T., El-Sherif A., Morris L., Seth R., Hibma M., Jenkins D., Lambert P., Coleman N., Doorbar J. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J. Virol. 2003, 77:10186-10201.
32. Moscicki A.B., Schiffman M., Kjaer S., Villa L.L. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 2006, 24(Suppl 3):S3/42-51.
33. Munger K., Baldwin A., Edwards K.M., Hayakawa H., Nguyen C.L., Owens M., Grace M., Huh K. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 2004, 78:11451-11460.
34. Nakamura M., Bodily J.M., Beglin M., Kyo S., Inoue M., Laimins L.A. Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses. Virology 2009, 387:442-448.
35. Ozbun M.A., Meyers C. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 1997, 71:5161-5172.
36. Ozbun M.A., Meyers C. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J. Virol. 1998, 72:2715-2722.
37. Parkin D.M., Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006, 24(Suppl 3):S11-25.
38. Peh W.L., Brandsma J.L., Christensen N.D., Cladel N.M., Wu X., Doorbar J. The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo. J. Virol. 2004, 78:2142-2151.
39. Peh W.L., Middleton K., Christensen N., Nicholls P., Egawa K., Sotlar K., Brandsma J., Percival A., Lewis J., Liu W.J., Doorbar J. Life cycle heterogeneity in animal models of human papillomavirus-associated disease. J. Virol. 2002, 76:10401-10416.
40. Rawls J.A., Pusztai R., Green M. Chemical synthesis of human papillomavirus type 16 E7 oncoprotein: autonomous protein domains for induction of cellular DNA synthesis and for trans activation. J. Virol. 1990, 64:6121-6129.
41. Richardson H., Kelsall G., Tellier P., Voyer H., Abrahamowicz M., Ferenczy A., Coutlee F., Franco E.L. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol. Biomarkers Prev. 2003, 12:485-490.
42. Ruesch M.N., Laimins L.A. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium. Virology 1998, 250:19-29.
43. Ruesch M.N., Stubenrauch F., Laimins L.A. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J. Virol. 1998, 72:5016-5024.
44. Schweiger M.R., Ottinger M., You J., Howley P.M. Brd4-independent transcriptional repression function of the papillomavirus e2 proteins. J. Virol. 2007, 81:9612-9622.
45. Simpson C.L., Patel D.M., Green K.J. Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis. Nature reviews. Mol.Cell Biol. 2011, 12:565-580.
46. Spink K.M., Laimins L.A. Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J. Virol. 2005, 79:4918-4926.
47. Stanley M. Immunobiology of HPV and HPV vaccines. Gynecol. Oncol. 2008, 109:S15-21.
48. Thierry F. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 2009, 384:375-379.
49. Watt F.M. Epidermal stem cells: markers, patterning and the control of stem cell fate. Philos. Trans. R. Soc. London, Ser. B 1998, 353:831-837.
50. Weinstock H., Berman S., Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect. Sexual Reproduct. Health 2004, 36:6-10.
51. Wilson R., Fehrmann F., Laimins L.A. Role of the E1^E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J. Virol. 2005, 79:6732-6740.
52. Wilson R., Laimins L.A. Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose. Methods Mol. Med. 2005, 119:157-169.
53. Woodman C.B., Collins S., Winter H., Bailey A., Ellis J., Prior P., Yates M., Rollason T.P., Young L.S. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001, 357:1831-1836.
54. Wu S.Y., Chiang C.M. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem. 2007, 282:13141-13145.
55. Yan J., Li Q., Lievens S., Tavernier J., You J. Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression. J. Virol. 2010, 84:76-87.
56. Zanet J., Freije A., Ruiz M., Coulon V., Sanz J.R., Chiesa J., Gandarillas A. A mitosis block links active cell cycle with human epidermal differentiation and results in endoreplication. PloS One 2010, 5:e15701.
57. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009, 384:260-265.